DeepNovoAA
downstream-application · CNN + RNN
DeepNovoAA: downstream-application · CNN + RNN. Immunopeptidome neoantigen discovery
Immunopeptidome neoantigen discovery
| Kind | downstream-application |
| Deep learning | yes |
| Acquisition | DDA |
| Family | CNN + RNN |
| Application area | Immunopeptidomics / neoantigen |
Code
Live stars, open issues and last-push figures are on the Code activity chart.
Patents (1)
- US20200243164A1 Systems and methods for patient-specific identification of neoantigens by de novo peptide sequencing for personalized immunotherapy ↗ (Bioinformatics Solutions Inc., priority 2019-01-30, abandoned)
Patent families that claim this method, matched by hand. A patent’s status is Google Patents’ reading of its legal events.
Papers describing it (2)
- Personalized deep learning of individual immunopeptidomes to identify neoantigens for cancer vaccines (2019, bioRxiv, preprint)
- Personalized deep learning of individual immunopeptidomes to identify neoantigens for cancer vaccines (2020, Nature Machine Intelligence, peer-reviewed)